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Editorial
Over the last decades, major increases in meats pro-
duction have occurred in developing countries and this
will continue – especially for poultry and pork. China
alone produces and consumes roughly half the planet’s
pigs—about 500 million annually [1].
The increase in animal husbandry and meat consump-
tion in developing countries parallels what happened in
developed countries over the last 100 years as incomes
rose. An unfortunate consequence of this increased meat
production has been the adoption of many poor prac-
tices from the developed world. When industrialised
meat production occurs this may result in poor animal
husbandry practices, over-crowding of animals and often
the use of huge volumes of antibiotics. Mass medication
with antibiotics continues for growth promotion, disease
prevention and therapeutic purposes worldwide [2-4].
Between 2010 and 2030, recent modelling suggests that
the global consumption of antimicrobials will increase
by 67%, from 63,000 tons to 105,000 tons. For Brazil,
Russia, India, China, and South Africa, the estimated in-
crease in antimicrobial consumption is 99% - up to
seven times the projected population growth in this
group of countries [2].
In developed countries reliable figures are only now be-
coming available in some countries. Data in the US shows
that up to 80% of all antibiotics by volume used were in
food production animals [5]. Growth promotion usage is a
major contributor to usage, even though data shows little
or no economic benefit to producers [6]. Some growth
promoters, such as avoparcin that was causing an increase
of vancomycin-resistant Enterococcus faecium, were banned
[6]. In other cases, countries and large industrial producers
have voluntarily stopped this routine use with little ad-
verse economic or animal health impacts [6-8].
Another argument used to justify antibiotics as growth
promoters of food animals was that the nutrition of
people in these countries will improve based on the pre-
sumption that this use will improve a populations’ pro-
tein intake. This is also unlikely to be true [9].
In this Journal, an article from Krishnasamy et al. [10]
gives estimates on the antibiotic volumes used in food
production in China. The authors give very good back-
ground information on the increasing meat production
that is occurring in developing countries, and specifically
in China. It notes that China is now the major meat pro-
duction country in the world - exceeding the US. This is
not surprising given China’s population and rising in-
come. The authors however adopted the same method-
ology used previously in the US to make their estimates
for usage in China, which is problematic. While their es-
timate may give an overall idea of what might be used in
China, there is no independent verification on what
types of antibiotics are used in China or of the quantities
used. Regulations and other controls will be different in
China compared to the US. We know that in the US
much higher amounts of antibiotics are used per kilo-
gram of pork production, compared to Denmark [11].
There are also major variations in the amounts and
types of antibiotics used in different countries in the EU
per Kg of meat produced [12]. Consequently, we assume
major variations in the volumes and types of antibiotics
used in the US compared to China. There are also many
other developing countries that are major food pro-
ducers and/or exporters, which include Brazil, Thailand
and India. China is also likely to have major variations in
usage patterns compared to these other countries.
While any attention to the general problem is of im-
portance, the major problem we have is the lack of data
worldwide on what types of antibiotics are used, in what
amounts and how they are used. Countries in Europe
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have currently the best available data [12]. Some animal
usage data has been available from Canada, US, Australia
and other developed countries [5,13,14]. However even
this data often can be a number of years out of date and
there is usually little information on which antibiotics are
used in what animals. Therefore we need to be wary about
over interpreting the data as presented for China [10] or
in models using data only from developed countries [2].
Worldwide we need better, more transparent and timely
collection and publication of data from both the human
and agriculture sectors. We need epidemiological insights
and trends on antibiotic resistant bacteria. This needs to
include those bacteria causing frequent and life threaten-
ing infections in people e.g. Staphylococcus aureus and
Escherichia coli blood stream infections. While this data is
now readily available for most EU countries [15], timely
and accurate antibiotic usage data for people and food ani-
mals in all countries are needed. In addition, molecular
epidemiological data are needed to better estimate the
zoonotic spread of multidrug-resistant micro-organisms
and their resistance genes from livestock to humans and
the environment.
What limited data is available from China suggests
large volumes of antibiotics are used. It is suggested that
nearly half of the 210,000 tonnes of antibiotics produced
in China are deployed in food animals [16]. Some studies
give data on what antibiotics are found in waterways and
manure in China, which gives an indirect idea of both
that the amounts used and types of antibiotics are used.
However this is still all only based on relatively limited
sample sizes. From the information available, it suggests
high volumes of sulphonamides, tetracyclines and fluor-
oquinolones (enrofloxacin, fleroxacin and norfloxacin)
are widely used in the agriculture sector there. However
differences are seen in antibiotics found in manure com-
pared to waterways [17-19]. This will vary depending on
what farms and types of animals are around these water-
ways plus differences between provinces on how and
what antibiotics are used.
The study by Krishnasamy et al. in this edition of the
journal [10] is a good start to try and estimate what may
be happening with antibiotic usage in food animals in the
developing world. However there are many methodo-
logical issues that need to be considered. What is beyond
doubt is that we have a major problem with antibiotic re-
sistance and that this problem is much worse in the devel-
oping countries. While many governments – importantly
including China and India - have taken steps to curtail
overuse of antibiotics by people, antibiotics in animal feed
are still poorly regulated.
Consequently, large volumes of antibiotics are used in
food animals contributing to the problem of antimicro-
bial resistance. In addition, water is frequently contami-
nated with large numbers of resistant bacteria and their
resistance genes - both by faecal contamination from
people (poor sanitation) and animal manure. This con-
taminated water then recirculates to people and food
animals given antibiotics, which then allows even more
resistance to develop and spread. In India a large pro-
portion of E.coli causing community onset urinary tract
infections because of antibiotic resistance are for prac-
tical purposes untreatable [20]. In many waterways in
India (and elsewhere) multi-resistant bacteria are fre-
quently present [21].
Antibiotic resistance needs to be tackled on multiple
fronts. Having good data on usage and resistance patterns
for both people and animals worldwide is an important
step to be able to better manage this problem. We need to
ensure that food and water sources do not become the pri-
mary source of multidrug-resistant micro-organism or
their resistance-genes. We need better approaches that
allow us to successfully restrict what and how antibiotics
are used in these different environments. “One Health”
has become a major buzzword in recent years, but imple-
menting this approach into practice seems to be some-
thing we have failed to pursue with any vigour.
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